You are on page 1of 21

Renub Research

www.renub.com
Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis
Influenza Cervical Cancer/ HPV Hepatitis Zoster Shingles Pneumococcal Measles, Mumps, Rubella and Varicella (MMRV) Meningococcal Diphtheria, Tetanus, Pertussis (DTP) Travel and Miscellaneous

Published: November, 2013


Copyright 2013 Renub Research All Rights Reserved

World Adult Vaccines Market Market Overview

For much of the 20th century, vaccines were a pharmaceutical success story largely associated with children. Aggressive immunization programs eradicated Polio and Smallpox among developed nations and nearly eliminated Mumps, Pertussis, Measles, and other diseases. While Pediatric Vaccines are an important market, it is now adults who are fueling growth of vaccine products. The world adult vaccines market is expected to nearly double by 2020 from the current figure of 2012. Vaccination has played an enormous role in the prevention of disease, having had the greatest impact on human health of any medical intervention. As a result, vaccine preventable diseases and their resulting deaths are now rare in the developed world. However, the developing nations have not benefited as much from the introduction of vaccines. Additionally, other issues such as vaccine safety, shortages and bioterrorism continue to weigh upon the industry. Renub Research study titled Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis provides a comprehensive assessment of the fast-evolving, high-growth of World Adult Vaccines Landscape. This 222 page report with 142 Figures and 15 Tables studies: 9 Adult Vaccines Market, 5 Companies Adult Vaccines Sales. In total 28 Adult Vaccines have been researched for this report. This report is broadly divided into 11 chapters. Adult Vaccines Market & Forecast data (2007 2020) covered in the report are as follows: 1. Influenza 2. Cervical Cancer/ HPV 3. Hepatitis 4. Zoster Shingles 5. Pneumococcal 6. Measles, Mumps, Rubella and Varicella (MMRV) 7. Meningococcal 8. Diphtheria, Tetanus, Pertussis (DTP) 9. Travel and Miscellaneous
Renub Research Page 2 of 21

Companies Adult Vaccines Sales Share and Forecast data (2007 2020) covered in the report 1. GlaxoSmithKline (GSK) 2. Sanofi Pasteur 3. Merck 4. Novartis 5. Pfizer 6. Others (Chapter 1): Executive Summary (Chapter 2): This Chapter is divided into 2 parts A. Adult Vaccines Market and Forecast data from 2007 to 2020 B. Adult Vaccinated Number and Forecast from 2007 to 2020 (Chapter 3): This chapter is divided into 3 parts A. Provides market share (percentage) of Adult Vaccines in the above mentioned vaccines B. Provides market share (percentage) of Adult Vaccinated in the above mentioned vaccines C. Provides above mentioned companies market share in Adult vaccines. (Chapter No. 4): This chapter is divided into 2 parts A. Companies given above Sales Share (percentage) in Disease Wise Break up & Forecast B. Adult Vaccines given above Companies Share and Forecast
Renub Research Page 3 of 21

(Chapter 5): This chapter talks about all the 9 Adult Vaccines mentioned above. All these vaccines have been further sub-divided into 4 parts A. Adult Vaccine Market & Forecast B. Number of Adults Being Vaccinated & Forecast C. Number of Adult Vaccines Doses & Forecast D. Number of Cases (Chapter 6): This chapter studies mentioned above all the 5 companies Adult Vaccines Sales and Forecast. The chapter further talks about the Company alliances with other Companies in order to increase their vaccine sales. (Chapter 7): This chapter studies mentioned above all the 5 companies Sales and Forecast Disease Wise (Chapter 8): This chapter provides Adult Vaccines Market and Forecast data of 8 Geographic Regions Worldwide. 1. United States 2. North America/Caribbean 3. South America 4. Europe 5. Japan 6. India 7. China 8. Rest of the World (ROW) (Chapter 9): This chapter comprises of important Mergers and Acquisitions happening in the field of vaccines

Renub Research

Page 4 of 21

(Chapter 10): This chapter studies growth Factors Driving the Adult Vaccines Market. In total 8 growth topics have been discussed in this chapter. (Chapter 11): This chapter studies Challenges/Hindrances faced by Adult Vaccines Market. In total 7 challenges topics have been discussed in this chapter

Data Sources This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Renub Research team of industry experts. Primary sources include industry surveys and telephone interviews with industry experts. Secondary sources information and data has been collected from various printable and nonprintable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Government Agencies, Magazines, Newspapers, Trade associations, Books, Industry Portals, Industry Associations and access to more than 500 paid databases.

Renub Research

Page 5 of 21

About Us
Renub Research
is a leading Market Research and Information Analysis Company with

centers at Noida India and Roswell USA. We have long-term experience especially in international Business-to-Business Researches, Surveys, Business and Consulting. Throughout the years we have acquired expertise in most market sectors, including Information Technology (IT), Telecoms, Life Sciences, Medical & Pharmaceuticals, Financial Services (Banking, Insurance, Reinsurance, M&A, etc.), Energy, Chemicals, Automotive, Retail, FMCG, Consumer Goods, Logistics, Governmental, Social, and Others. Our core team is comprised of an experienced people holding graduate, post graduate and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science and many more. Our research help make the business decisions: on strategy, organization, operations, technology, mergers & acquisitions etc. We support many blue chip companies by providing them findings and perspectives across a wide range of markets. Our research reports offer a blend of information insight, analysis and forecasting that is essential in todays ultra-competitive markets.

For more information on us or to view any of our sample work you can mail us at info@renub.com

Renub Research

Page 6 of 21

Published By

Renub Research
1st Floor, C-86, Sector10 Noida 201301 Phone: +91-120-421-9822, 254-5750 (India) +1-678-302-0700 (USA) Fax : +91-120-424-9780 Email: info@renub.com www.renub.com

Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines Worldwide Analysis Renub Research, 2013 Edition 1.0 All rights reserved. This publication is protected by copyright. No part of it may be reproduced, stored in a retrieval system or transmitted, in any form or by any means, electronic mechanical, photocopying, recording or otherwise without the prior written permission of the publishers

Renub Research

Page 7 of 21

Table of Contents
1. 2. Executive Summary World Adult Vaccine Analysis & Forecast (2007 2020) 2.1 2.2 3. World Adult Vaccine Market & Forecast World Adult Vaccine Number of Adults Being Vaccinated & Forecast

World Adult Vaccine Market Share Analysis & Forecast (2010 2020) 3.1 3.2 3.3 Disease Wise Market Share & Forecast (2010 2020) Disease Wise Percentage of Adults Being Vaccinated Share & Forecast (2010 2020) Company Wise Market Share & Forecast (2010 2020)

4.

World Adult Vaccine Sales Company Analysis Share & Forecast (2010 2020) 4.1 Companies Adult Vaccine Sales Disease Wise Break up Share & Forecast (2010 2020) GlaxoSmithKline (GSK) - Adult Vaccines Sales Share & Forecast Sanofi Pasteur - Adult Vaccines Sales Share & Forecast Merck - Adult Vaccines Sales Share & Forecast Novartis - Adult Vaccines Sales Share & Forecast

4.1.1 4.1.2 4.1.3 4.1.4 4.2

Adult Vaccine Disease Wise Market Break up - Company Share & Forecast (2010 2020) Influenza Adult Vaccines Company Market Share Cervical Cancer/HPV Adult Vaccines Company Market Share Hepatitis Adult Vaccines Company Market Share & Forecast Pneumococcal Adult Vaccines Company Market Share & Forecast Meningococcal Adult Vaccines Company Market Share & Forecast DTP (Diphtheria, Tetanus, Pertussis) Adult Vaccines Company Market Share & Forecast

4.2.1 4.2.2 4.2.3 4.2.4 4.2.5 4.2.6 5.

World Adult Vaccine Market Disease Wise Segmentation Analysis 5.1 Influenza Adult Vaccine Analysis & Forecast (2007 2020) Influenza Adult Vaccine Market & Forecast Influenza Number of Adults Being Vaccinated & Forecast Influenza Number of Vaccines Doses & Forecast

5.1.1 5.1.2 5.1.3 5.2

Cervical Cancer/ HPV Analysis (2007 2020) Cervical Cancer/ HPV Adult Vaccine Market & Forecast Cervical Cancer/ HPV Number of Adults Being Vaccinated & Forecast Cervical Cancer/ HPV Number of Vaccines Doses & Forecast

5.2.1 5.2.2 5.2.3

Renub Research

Page 8 of 21

5.2.4 5.3

Cervical Cancer/HPV - Number of New Cases & Forecast

Zoster Shingles Adult Vaccine Analysis (2006 2020) Zoster Shingles Adult Vaccine Market & Forecast Zoster Shingles Number of Adults Being Vaccinated & Forecast Zoster Shingles Number of Vaccine Doses & Forecast

5.3.1 5.3.2 5.3.3 5.4

Pneumococcal Adult Vaccine Analysis (2010 2020) Pneumococcal Adult Vaccine Market & Forecast Pneumococcal Number of Adults Being Vaccinated & Forecast Pneumococcal Number of Vaccine Doses & Forecast

5.4.1 5.4.2 5.4.3 5.5

Meningococcal Adult Vaccine Analysis Meningococcal Adult Vaccine Market & Forecast Meningococcal Number of Adults Being Vaccinated & Forecast Meningococcal Number of Vaccines Doses & Forecast

5.5.1 5.5.2 5.5.3 5.6

Measles, Mumps, Rubella and Varicella (MMRV) Adult Vaccine Analysis Measles, Mumps, Rubella and Varicella (MMRV) Adult Vaccine Market & Forecast Measles, Mumps, Rubella and Varicella (MMRV) Number of Adults Being Vaccinated & Measles, Mumps, Rubella and Varicella (MMRV) Number of Vaccines Doses & Forecast MMR - Number of New Cases & Forecast

5.6.1 5.6.2 Forecast 5.6.3 5.6.4 5.7

Hepatitis Adult Vaccine Market Analysis Hepatitis Adult Vaccine Market & Forecast Hepatitis Number of Adults Being Vaccinated & Forecast Hepatitis Number of vaccine Doses & Forecast Hepatitis Number of Acute (New) Cases

5.7.1 5.7.2 5.7.3 5.7.4 5.8

Diphtheria, Tetanus, Pertussis (DTP) Adult Vaccine Market Analysis DTP (Diphtheria, Tetanus, Pertussis) Adult Vaccine Market & Forecast Diphtheria, Tetanus, Pertussis (DTP) Number of Adults Being Vaccinated & Forecast DTP - Number of Vaccines Doses & Forecast Diphtheria, Tetanus & Pertussis (DTP) - Number of Cases

5.8.1 5.8.2 5.8.3 5.8.4 5.9 6.

Travel and Miscellaneous Adult Vaccine Market

World Adult Vaccine Market Company Analysis & Strategic Alliances 6.1 GlaxoSmithKline GlaxoSmithKline (GSK) - Adult Vaccine Sales & Forecast Strategic Alliances of GlaxoSmithKline (GSK)

6.1.1 6.1.2

Renub Research

Page 9 of 21

6.2

Sanofi Pasteur Sanofi Pasteur Vaccines Sales Analysis Strategic Alliances of Sanofi Pasteur

6.2.1 6.2.2 6.3

Merck Merck Vaccines Sales Analysis Strategic Alliances of Merck

6.3.1 6.3.2 6.4

Novartis Novartis Vaccines Sales Analysis Strategic Alliances of Novartis

6.4.1 6.4.2 6.5

Pfizer Pfizer Adult Vaccines Sales & Forecast Strategic Alliances of Pfizer

6.5.1 6.5.2 6.6 7.

Other Companies

World Adult Vaccine Company Sales Disease Wise Break up & Forecast (2007 2020) 7.1 GlaxoSmithKline (GSK) Adult Vaccines Sales & Forecast GlaxoSmithKline (GSK) Influenza Adult Vaccines Sales & Forecast GlaxoSmithKline (GSK) Cervical Cancer/HPV Adult Vaccines Sales & Forecast GlaxoSmithKline (GSK) Hepatitis Adult Vaccines Sales & Forecast GlaxoSmithKline (GSK) DTP Adult Vaccines Sales & Forecast

7.1.1 7.1.2 7.1.3 7.1.4 7.2

Sanofi Pasteur Adult Vaccines Sales & Forecast Sanofi Pasteur Influenza Adult Vaccines Sales & Forecast Sanofi Pasteur DTP Adult Vaccines Sales & Forecast Sanofi Pasteur Meningococcal Adult Vaccines Sales & Forecast

7.2.1 7.2.2 7.2.3 7.3

Merck Adult Vaccines Sales & Forecast Merck Influenza Adult Vaccines Sales & Forecast Merck Cervical Cancer/HPV Adult Vaccines Sales & Forecast Merck Zoster Shingles Adult Vaccines Sales & Forecast Merck Pneumococcal Adult Vaccines Sales & Forecast Merck MMRV Adult Vaccines Sales & Forecast Merck Hepatitis Adult Vaccines Sales & Forecast

7.3.1 7.3.2 7.3.3 7.3.4 7.3.5 7.3.6 7.4

Novartis Adult Vaccines Sales & Forecast Novartis Influenza Adult Vaccines Sales & Forecast Novartis Meningococcal Adult Vaccines Sales & Forecast

7.4.1 7.4.2 7.5

Pfizer Adult Vaccines Sales & Forecast

Renub Research

Page 10 of 21

7.5.1 8.

Pfizer Pneumococcal Adult Vaccines Sales & Forecast

World Adult Vaccine Market Geographical Distribution 8.1 8.2 8.3 8.4 8.5 8.6 8.7 8.8 United States Adult Vaccine Market & Forecast North America/Caribbean Adult Vaccine Market & Forecast South America Adult Vaccine Market & Forecast Europe Adult Vaccine Market & Forecast Japan Adult Vaccine Market & Forecast India Adult Vaccine Market & Forecast China Adult Vaccine Market & Forecast Rest of the World (ROW) Adult Vaccine Market & Forecast

9. 10.

Major Vaccine Related Acquisitions (2005-2012) Growth Factors for Adult Vaccines Global Immunization Vision and Strategy (GIVS) GAVI Model Fuelling Vaccine Manufacturers The Partnership Model The Business Model

10.1 10.2

10.2.1 10.2.2 10.3 10.4 10.5 10.6 10.7 10.8 11. 11.1

Increasing Vaccine Availability in United States The Vaccine Safety Data link Project The Vaccine Injury Compensation Program Transforming of Vaccine Technologies Global Vaccine Action Plan by WHO (2011 - 2020) Continuous Focus on Effective Communication Strategies Challenges for Adult Vaccines Market Hurdles to Optimal use of Licensed Vaccines Technical Obstacles Economic obstacles Cultural Obstacles

11.1.1 11.1.2 11.1.3 11.2

Complexity of Vaccine Development & Approval System Thwarts Product Development Legal Obstacles General Technical Barriers Page 11 of 21

11.2.1 11.2.2

Renub Research

11.2.3 11.2.4 11.3 11.4

Economic Barriers Regulatory Barriers

Shortening the Timeline for Vaccine Development Refusal/Resistance to Vaccination Vaccine Adverse Event Reporting System

11.4.1 11.5 11.6 11.7

Vaccine Shortages and Delays Obstacles in Vaccine Research & Development Barriers to New Entrants in the Vaccines Market

Renub Research

Page 12 of 21

List of Figures
Figure 2-1: Worldwide Adult Vaccine Market (Million US$), 2007 2012 Figure 2-2: Worldwide Forecast for Adult Vaccine Market (Million US$), 2013 2020 Figure 2-3: Worldwide Number of Adults Being Vaccinated with Adult Vaccines (Million), 2007 2012 Figure 2-4: Worldwide Forecast for Number of Adults Being Vaccinated with Adult Vaccines (Million), 2013 2020 Figure 3-1: Worldwide Diseases Wise Adult Vaccine Market Share (Percent), 2010 2012 Figure 3-2: Worldwide Forecast for Diseases Wise Adult Vaccine Market Share (Percent), 2013 2020 Figure 3-3: Worldwide Company Wise Adult Vaccine Market Share (Percent), 2010 2012 Figure 3-4: Worldwide Forecast for Company Wise Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-1: Worldwide GSK Adult Vaccine Sales Share (Percent), 2007 2012 Figure 4-2: Worldwide Forecast for GSK Adult Vaccine Sales Share (Percent), 2013 2020 Figure 4-3: Worldwide Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2010 2012 Figure 4-4: Worldwide Forecast for Sanofi Pasteur Adult Vaccine Sales Share (Percent), 2013 2020 Figure 4-5: Worldwide Merck Adult Vaccine Sales Share (Percent), 2010 2012 Figure 4-6: Worldwide Forecast for Merck Adult Vaccine Sales Share (Percent), 2013 2020 Figure 4-7: Worldwide Forecast for Novartis Adult Vaccine Sales Share (Percent), 2010 2012 Figure 4-8: Worldwide Forecast for Novartis Adult Vaccine Sales Share (Percent), 2013 2020 Figure 4-9: Worldwide Influenza Adult Vaccine Market Share (Percent), 2010 2012 Figure 4-10: Worldwide Forecast for Influenza Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-11: Worldwide Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2007 2012 Figure 4-12: Worldwide Forecast for Cervical Cancer/HPV Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-13: Worldwide Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2008 2012 Figure 4-14: Worldwide Forecast for Hepatitis Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-15: Worldwide Pneumococcal Adult Vaccine Market Share (Percent), 2010 2012 Figure 4-16: Worldwide Forecast for Pneumococcal Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-17: Worldwide Meningococcal Adult Vaccine Market Share (Percent), 2010 2012 Figure 4-18: Worldwide Forecast for Meningococcal Adult Vaccine Market Share (Percent), 2013 2020 Figure 4-19: Worldwide DTP Adult Vaccine Market Share (Percent), 2010 2012 Figure 4-20: Worldwide Forecast for DTP Adult Vaccine Market Share (Percent), 2013 2020 Figure 5-1: Worldwide Influenza Adult Vaccine Market (Million US$), 2007 2012 Figure 5-2: Worldwide Forecast for Influenza Adult Vaccine Market (Million US$), 2013 2020 Figure 5-3: Worldwide Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2007 2012 Figure 5-4: Worldwide Forecast for Number of Adults Being Vaccinated with Influenza Vaccine (Million), 2013 2020

Renub Research

Page 13 of 21

Figure 5-5: Worldwide Number of Influenza Vaccine Doses (Million), 2007 2012 Figure 5-6: Worldwide Forecast for Number of Influenza Vaccine Doses (Million), 2013 2020 Figure 5-7: Worldwide Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2007 2012 Figure 5-8: Worldwide Forecast for Cervical Cancer/HPV Adult Vaccine Market (Million US$), 2013 2020 Figure 5-9: Worldwide Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2007 2012 Figure 5-10: Worldwide Forecast for Number of Adults Being Vaccinated with Cancer/HPV Vaccines (Million), 2013 2020 Figure 5-11: Worldwide Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2007 2012 Figure 5-12: Worldwide Forecast for Number of Cervical Cancer/ HPV Vaccine Doses (Million), 2013 2020 Figure 5-13: Worldwide Zoster Shingles Adult Vaccine Market (Million US$), 2006 2012 Figure 5-14: Worldwide Forecast for Zoster Shingles Adult Vaccine Market (Million US$), 2013 2020 Figure 5-15: Worldwide Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2006 2012 Figure 5-16: Worldwide Forecast for Number of Adults Being Vaccinated with Zoster Shingles Vaccines (Million), 2013 2020 Figure 5-17: Worldwide Number of Zoster Shingles Vaccine Doses (Million US$), 2007 2012 Figure 5-18: Worldwide Forecast for Number of Zoster Shingles Vaccine Doses (Million US$), 2013 2020 Figure 5-19: Worldwide Pneumococcal Adult Vaccine Market (Million US$), 2010 2012 Figure 5-20: Worldwide Forecast for Pneumococcal Adult Vaccine Market (Million US$), 2013 2020 Figure 5-21: Worldwide Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2010 2012 Figure 5-22: Worldwide Forecast for Number of Adults Being Vaccinated with Pneumococcal Vaccines (Million), 2013 2020 Figure 5-23: Worldwide Number of Pneumococcal Vaccines Doses (Million), 2010 2012 Figure 5-24: Worldwide Forecast for Number of Pneumococcal Vaccines Doses (Million), 2013 2020 Figure 5-25: Worldwide Meningococcal Adult Vaccine Market (Million US$), 2010 2012 Figure 5-26: Worldwide Forecast for Meningococcal Adult Vaccine Market (Million US$), 2013 2020 Figure 5-27: Worldwide Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2010 2012 Figure 5-28: Worldwide Forecast for Number of Adults Being Vaccinated with Meningococcal Vaccines (Million), 2013 2020 Figure 5-29: Worldwide Number of Meningococcal Vaccines Doses (Million), 2010 2012 Figure 5-30: Worldwide Forecast for Number of Meningococcal Vaccines Doses (Million), 2013 2020

Renub Research

Page 14 of 21

Figure 5-31: Worldwide MMRV Adult Vaccine Market (Million US$), 2007 2012 Figure 5-32: Worldwide Forecast for MMRV Adult Vaccine Market (Million US$), 2013 2020 Figure 5-33: Worldwide Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2007 2012 Figure 5-34: Worldwide Forecast for Number of Adults Being Vaccinated with MMRV Vaccines (Million), 2013 2020 Figure 5-35: Worldwide Number of MMRV Vaccines Doses (Million), 2007 2012 Figure 5-36: Worldwide Forecast for Number of MMRV Vaccines Doses (Million), 2013 2020 Figure 5-37: Worldwide Hepatitis Adult Vaccine Market (Million US$), 2007 2012 Figure 5-38: Worldwide Forecast for Hepatitis Adult Vaccine Market (Million US$), 2013 2020 Figure 5-39: Worldwide Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2007 2012 Figure 5-40: Worldwide Forecast for Number of Adults Being Vaccinated with Hepatitis Vaccines (Million), 2013 2020 Figure 5-41: Worldwide Number of Hepatitis Vaccines Doses (Million), 2007 2012 Figure 5-42: Worldwide Forecast for Number of Hepatitis Vaccines Doses (Million), 2013 2020 Figure 5-43: United States Reported Acute (New) Cases of Hepatitis A Virus (Number), 2005 2011 Figure 5-44: United States Reported Acute (New) Cases of Hepatitis B Virus (Number), 2005 2011 Figure 5-45: Worldwide DTP Adult Vaccine Market (Million US$), 2010 2012 Figure 5-46: Worldwide Forecast for DTP Adult Vaccine Market (Million US$), 2013 2020 Figure 5-47: Worldwide Number of Adults Being Vaccinated with DTP Vaccines (Million), 2010 2012 Figure 5-48: Worldwide Forecast for Number of Adults Being Vaccinated with DTP (Million), 2013 2020 Figure 5-49: Worldwide Number of DTP Vaccine Doses (Million), 2010 2012 Figure 5-50: Worldwide Forecast for Number of DTP Vaccine Doses (Million), 2013 2020 Figure 5-51: Worldwide Travel and Misc. Adult Vaccine Market (Million US$), 2007 2012 Figure 5-52: Worldwide Forecast For Travel and Misc. Adult Vaccine Market (Million US$), 2013 2020 Figure 6-1: Worldwide GlaxoSmithKline Adult Vaccines Sales (Million US$), 2007 2012 Figure 6-2: Worldwide Forecast for GlaxoSmithKline Adult Vaccines Sales (Million US$), 2013 2020 Figure 6-3: Worldwide Sanofi Pasteur Adult Vaccines Sales (Million US$), 2010 2012 Figure 6-4: Worldwide Forecast for Sanofi Pasteur Adult Vaccines Sales (Million US$), 2013 2020 Figure 6-5: Worldwide Merck Adult Vaccines Sales (Million US$), 2007 2012 Figure 6-6: Worldwide Forecast for Merck Adult Vaccines Sales (Million US$), 2013 2020 Figure 6-7: Worldwide Novartis Adult Vaccines Sales (Million US$), 2010 2012 Figure 6-8: Worldwide Forecast for Novartis Adult Vaccines Sales (Million US$), 2013 2020 Figure 6-9: Worldwide Pfizer Adult Vaccines Sales (Million US$), 2010 2012 Figure 6-10: Worldwide Forecast for Pfizer Adult Vaccines Sales (Million US$), 2013 2020 Figure 6-11: Worldwide Other Companies Adult Vaccines Sales (Million US$), 2010 2012 Figure 6-12: Worldwide Forecast for Other Companies Adult Vaccines Sales (Million US$), 2013 2020

Renub Research

Page 15 of 21

Figure 7-1: Worldwide GSK Influenza Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-2: Worldwide Forecast for GSK Influenza Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-3: Worldwide GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-4: Worldwide Forecast for GSK Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-5: Worldwide GSK Hepatitis Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-6: Worldwide Forecast for GSK Hepatitis Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-7: Worldwide GSK DTP Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-8: Worldwide Forecast for GSK DTP Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-9: Worldwide Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2009 2012 Figure 7-10: Worldwide Forecast for Sanofi Pasteur Influenza Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-11: Worldwide Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2010 2012 Figure 7-12: Worldwide Forecast for Sanofi Pasteur DTP Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-13: Worldwide Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2009 2012 Figure 7-14: Worldwide Forecast for Sanofi Pasteur Meningococcal Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-15: Worldwide Merck Influenza Adult Vaccines Sales (Million US$), 2010 2012 Figure 7-16: Worldwide Forecast for Merck Influenza Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-17: Worldwide Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-18: Worldwide Forecast for Merck Cervical Cancer/HPV Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-19: Worldwide Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-20: Worldwide Forecast for Merck Zoster Shingles Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-21: Worldwide Merck Pneumococcal Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-22: Worldwide Forecast for Merck Pneumococcal Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-23: Worldwide Merck MMRV Adult Vaccines Sales (Million US$), 2007 2012 Figure 7-24: Worldwide Forecast for Merck MMRV Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-25: Worldwide Merck Hepatitis Adult Vaccines Sales (Million US$), 2008 2012 Figure 7-26: Worldwide Forecast for Merck Hepatitis Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-27: Worldwide Novartis Influenza Adult Vaccines Sales (Million US$), 2010 2012 Figure 7-28: Worldwide Forecast for Novartis Influenza Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-29: Worldwide Novartis Meningococcal Adult Vaccines Sales (Million US$), 2010 2012

Renub Research

Page 16 of 21

Figure 7-30: Worldwide Forecast for Novartis Meningococcal Adult Vaccines Sales (Million US$), 2013 2020 Figure 7-31: Worldwide Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2010 2012 Figure 7-32: Worldwide Forecast for Pfizer Pneumococcal Adult Vaccines Sales (Million US$), 2013 2020 Figure 8-1: United States Adult Vaccines Market (Million US$), 2007 2012 Figure 8-2: United States Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-3: North America/Caribbean Adult Vaccines Market (Million US$), 2007 2012 Figure 8-4: North America/Caribbean Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-5: South America Adult Vaccines Market (Million US$), 2007 2012 Figure 8-6: South America Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-7: Europe Adult Vaccines Market (Million US$), 2007 2012 Figure 8-8: Europe Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-9: Japan Adult Vaccines Market (Million US$), 2007 2012 Figure 8-10: Japan Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-11: India Adult Vaccines Market (Million US$), 2007 2012 Figure 8-12: India Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-13: China Adult Vaccines Market (Million US$), 2007 2012 Figure 8-14: China Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 8-15: ROW Adult Vaccines Market (Million US$), 2007 2012 Figure 8-16: ROW Forecast for Adult Vaccines Market (Million US$), 2013 2020 Figure 10-1: Increasing Number of GAVI Suppliers Based in Emerging Markets, 2001 2011 Figure 10-2: US Number of Retail Clinics offering Vaccination (Number), 2007 2012

Renub Research

Page 17 of 21

List of Tables
Table 3-1: Worldwide Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2010 2012 Table 3-2: Worldwide Forecast for Share of Adults Being Vaccinated with Adult Vaccines (Percent), 2013 2020 Table 5-1: Cervical Cancer Region Wise Number of New Cancer Cases (Number), 2009 2012 Table 5-2: Cervix Forecast for Region Wise Number of New Cancer Cases (Number), 2013 2018 Table 5-3: Worldwide (By Geographic Region) Number of Measles Cases (Number), 2001 2012 Table 5-4: Worldwide (By Geographic Region) Number of Mumps Cases (Number), 2001 2012 Table 5-5: Worldwide (By Geographic Region) Number of Rubella Cases (Number), 2001 2011 Table 5-6: Worldwide (By Geographic Region) Number of Diphtheria Cases (Number), 2001 2012 Table 5-7: Worldwide (By Geographic Region) Number of nTetanus Cases (Number), 2001 2012 Table 5-8: Worldwide (By Geographic Region) Number of tTetanus Cases (Number), 2001 2012 Table 5-9: Worldwide (By Geographic Region) Number of Pertussis Cases (Number), 2001 2012 Table 9-1: Worldwide Major Vaccine Related Acquisitions, (2005 2012) Table 10-1: Worldwide Total Future Deaths Averted through Vaccination (Million), 2011 2020 Table 10-2: Goal-Level Indicators, 2015 & 2020 Table 10-3: Improvement Strategies or Requirements the Joint Commission and the Projects Collaborating Organizations

Renub Research

Page 18 of 21

Order Form
Scan and e-mail this page to info@renub.com. Else you can also fax this form to +91-120-4249780 Questions? Please call info@renub.com +91-120-421-9822 (India), +1-678-302-0700 (USA) or mail to

Format
Report Title: Adult Vaccines Market, Company Adult Vaccines Sales, Country Adult Vaccines - Worldwide Analysis

Single User (Email from Publisher) US$ 1,990

Hard Copy (Mail Delivery) US$ 2,240

CD Rom (Mail Delivery) US$ 2,090

Global Site License (Multiple User License) US$ 2,800

For ordering this report: Three easy ways to place your order:
1) Order online by Credit Card (Visa, MasterCard, etc.): http://www.renub.com/report/adult-vaccines-market-company-adult-vaccines-sales-countryadult-vaccines---worldwide-analysis-126 2) Order by Wire Transfer: http://www.renub.com/report/wiretransfer.aspx?id=126&pid=1501 To pay by Wire Transfer, please, fill in your contact details in the form below:

Renub Research

Page 19 of 21

Bank Details
Account Name: Renub Research A/C No.: 109102000023296 Name of Bank: IDBI Bank Ltd. Swift Code: IBKLINBB010 Bank Address: 4th Floor Indian Red Cross Building 1 Red Cross Road Opposite Parliament Street New Delhi 110001 India

Contact Information
First Name: Email: Job Title: Company: Address: City: Postal/Zip Code: Country: Phone: Mobile: Fax: Report Format: Your message: Last Name:

Renub Research

Page 20 of 21

3) Order by Check Please post the check accompanied by this form, to: Company Address: Renub Research 1st Floor, C-86, Sector-10 Noida - 201301 Uttar Pradesh India Phone: +91-120-421-9822, 424-9780

For free Sample copy report or to view any of our sample work please contact us at info@renub.com or call +91-120-421-9822 (India), +1-678-302-0700 (USA)

Follow Us
Facebook: http://www.facebook.com/pages/Renub-Research/233380966701090 LinkedIn: http://www.linkedin.com/company/renub-research Twitter: http://twitter.com/RenubResearch

Renub Research

Page 21 of 21